儿童免疫性血小板减少症恢复评分:预测一过性与持续性ITP
该研究基于两项前瞻性多中心研究(NOPHO ITP研究N=377为开发队列,TIKI试验N=194为外部验证),开发并外部验证了儿童ITP恢复评分,用于预测新诊断ITP患儿一过性与持续性ITP。外部验证中该评分预测3个月随访时一过性与持续性ITP的AUC为0.71,且能预测出血症状停止和静脉免疫球蛋白(IVIg)反应。
要点
- 儿童ITP恢复评分可预测3个月时一过性与持续性ITP,外部验证AUC为0.71。
- 预测高恢复概率者3、6、12个月恢复率分别为85%、90%、95%;低概率者为32%、46%、71%。
- 评分还可预测出血症状停止及对IVIg的反应,有助于个体化管理。
核心结论
- 儿童ITP恢复评分可预测新诊断ITP患儿一过性与持续性ITP的预后,并可能有助于个体化临床管理。
研究设计与样本
- 基于两项前瞻性多中心研究开发并外部验证:NOPHO ITP研究(N=377)为开发队列,TIKI试验(N=194)为外部验证。
- 纳入标准为诊断时血小板计数≤20×10^9/L且年龄低于16岁的患儿。
主要发现
- 外部验证中,评分预测3个月随访时一过性与持续性ITP的受试者工作特征曲线下面积(AUC)为0.71。
- 预测高恢复概率者3、6、12个月恢复率分别为85%、90%、95%;预测低恢复概率者分别为32%、46%、71%。
- 评分还可预测出血症状停止和对静脉免疫球蛋白(IVIg)的反应。
关键数值与推荐
- 主要结局为一过性ITP(诊断后3个月血小板≥100×10^9/L的完全恢复)与持续性ITP。
- 预测因子包括年龄、性别、黏膜出血、前驱感染/疫苗接种、隐匿起病和诊断时血小板计数。
临床怎么用
- 该评分可用于预测新诊断儿童ITP的预后,辅助临床医生个体化患者管理。
- 风险计算器已在线提供(http://www.itprecoveryscore.org)。
局限性
- 未来研究可将生物标志物的附加预测价值与该评分进行比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials There is a need for improved tools to predict persistent and chronic immune thrombocytopenia (ITP). We developed and validated a clinical prediction model for recovery from newly diagnosed ITP. The Childhood ITP Recovery Score predicts transient vs. persistent ITP and response to intravenous immunoglobulins. The score may serve as a useful tool for clinicians to individualize patient care. ABSTRACT: Background Childhood immune thrombocytopenia (ITP) is an autoimmune bleeding disorder. The prognosis (transient, persistent, or chronic ITP) remains difficult to predict. The morbidity is most pronounced in children with persistent and chronic ITP. Clinical characteristics are associated with ITP outcomes, but there are no validated multivariate prediction models. Objective Development and external validatation of the Childhood ITP Recovery Score to predict transient versus persistent ITP in children with newly diagnosed ITP. Methods Patients with a diagnosis platelet count ≤ 20 × 109 /L and age below 16 years were included from two prospective multicenter studies (NOPHO ITP study, N = 377 [development cohort]; TIKI trial, N = 194 [external validation]). The primary outcome was transient ITP (complete recovery with platelets ≥100 × 109 /L 3 months after diagnosis) versus persistent ITP. Age, sex, mucosal bleeding, preceding infection/vaccination, insidious onset, and diagnosis platelet count were used as predictors. Results In external validation, the score predicted transient versus persistent ITP at 3 months follow-up with an area under the receiver operating characteristic curve of 0.71. In patients predicted to have a high chance of recovery, we observed 85%, 90%, and 95% recovered 3, 6, and 12 months after the diagnosis. For patients predicted to have a low chance of recovery, this was 32%, 46%, and 71%. The score also predicted cessation of bleeding symptoms and the response to intravenous immunoglobulins (IVIg). Conclusion The Childhood ITP Recovery Score predicts prognosis and may be useful to individualize clinical management. In future research, the additional predictive value of biomarkers can be compared to this score. A risk calculator is available (http://www.itprecoveryscore.org).
引用
- Schmidt DE, Wendtland Edslev P, Heitink-Pollé KMJ, et al. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia. J Thromb Haemost. 2020. PMID: 33058474. doi:10.1111/jth.15125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。